Abstract:The mRNAs of higher eukaryotes are extensively modified internally with N6-methyladenosine, but the specific functional role of this modification has been unclear; here this modification on mRNA is shown to be recognized by several proteins, the modification and its recognition serve to regulate the RNA’s lifetime. The messenger RNAs of higher eukaryotes are extensively modified with N6-methyladenosine, but the functional role of this modification has been unclear. Chuan He and colleagues now show that in human cells, these modified bases are recognized by a family of proteins, YTHDF2, not only in mRNAs, but also in a variety of non-coding RNAs. Once bound, these proteins mediate degradation of the RNA by targeting it to cellular RNA decay sites. In this way, the modification serves as a regulator of the RNA's lifetime. N6-methyladenosine (m6A) is the most prevalent internal (non-cap) modification present in the messenger RNA of all higher eukaryotes1,2. Although essential to cell viability and development3,4,5, the exact role of m6A modification remains to be determined. The recent discovery of two m6A demethylases in mammalian cells highlighted the importance of m6A in basic biological functions and disease6,7,8. Here we show that m6A is selectively recognized by the human YTH domain family 2 (YTHDF2) ‘reader’ protein to regulate mRNA degradation. We identified over 3,000 cellular RNA targets of YTHDF2, most of which are mRNAs, but which also include non-coding RNAs, with a conserved core motif of G(m6A)C. We further establish the role of YTHDF2 in RNA metabolism, showing that binding of YTHDF2 results in the localization of bound mRNA from the translatable pool to mRNA decay sites, such as processing bodies9. The carboxy-terminal domain of YTHDF2 selectively binds to m6A-containing mRNA, whereas the amino-terminal domain is responsible for the localization of the YTHDF2–mRNA complex to cellular RNA decay sites. Our results indicate that the dynamic m6A modification is recognized by selectively binding proteins to affect the translation status and lifetime of mRNA.

m6A enhances the phase separation potential of mRNA

M(6)a Facilitates YTHDF-independent Phase Separation

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

Binding to M6a RNA Promotes YTHDF2-mediated Phase Separation

M6a-Binding Proteins: the Emerging Crucial Performers in Epigenetics

Effects of Exogenous N6-methyladenosine Incorporation on the Expression of Cellular mRNA Transcripts

N6-Methyladenosine on Mrna Facilitates a Phase-Separated Nuclear Body That Suppresses Myeloid Leukemic Differentiation

Modulation of Phase Separation by RNA: A Glimpse on N6-Methyladenosine Modification

N 6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

N6-methyladenosine-dependent Regulation of Messenger RNA Stability.

N-6-methyladenosine (m6A) Promotes the Nuclear Retention of mRNAs with Intact 5' Splice Site Motifs

Structural Insights into N 6 -Methyladenosine (m 6 A) Modification in the Transcriptome

N6-methyladenosine RNA methylation modulates liquid‒liquid phase separation in plants.

Limited effects of m6A modification on mRNA partitioning into stress granules

Understanding the redundant functions of the m6A-binding YTHDF proteins

Rna Modification N-6-Methyladenosine in Post-Transcriptional Regulation

Reading, writing and erasing mRNA methylation

Comprehensive analysis across mammalian tissues and cells decipher the underlying mechanism of m6A specificity

Dynamic assembly of the mRNA m6A methyltransferase complex is regulated by METTL3 phase separation

Passive shaping of intra- and intercellular m6A dynamics via mRNA metabolism